|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.65 USD | +0.55% |
|
-1.88% | -16.67% |
| 05-09 | Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| 05-09 | Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Eton Pharmaceuticals, Inc. provided revenue guidance for the year 2023. For the year, the company expects total revenue to be approximately $30 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.67% | 93.76M | |
| +14.85% | 78.37B | |
| +11.98% | 9.08B | |
| -12.85% | 5.06B | |
| +54.35% | 4.85B | |
| +15.78% | 2.37B | |
| -20.85% | 2.36B | |
| +24.62% | 2.27B | |
| -29.25% | 2.22B | |
| -0.50% | 1.64B |
ETON PHARMACEUTICALS, INC. 
